Alethia Young

Stock Analyst at Cantor Fitzgerald

(2.94)
# 1,650
Out of 5,045 analysts
141
Total ratings
54.46%
Success rate
30.69%
Average return

Stocks Rated by Alethia Young

Arcus Biosciences
Jul 5, 2024
Reiterates: Overweight
Price Target: n/a
Current: $20.19
Upside: -
Arrowhead Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $42.31
Upside: -
Regeneron Pharmaceuticals
Oct 16, 2023
Maintains: Neutral
Price Target: $800$850
Current: $654.04
Upside: +29.96%
ALX Oncology Holdings
Sep 12, 2023
Reiterates: Overweight
Price Target: $18
Current: $1.55
Upside: +1,061.29%
Curis
Sep 7, 2023
Reiterates: Overweight
Price Target: $60
Current: $1.49
Upside: +3,926.85%
Eledon Pharmaceuticals
Aug 22, 2023
Reiterates: Overweight
Price Target: $9
Current: $4.35
Upside: +106.90%
Verastem
Jul 6, 2023
Reiterates: Overweight
Price Target: $34
Current: $9.23
Upside: +268.36%
Biogen
Oct 15, 2021
Maintains: Neutral
Price Target: $427$327
Current: $149.61
Upside: +118.57%
Adverum Biotechnologies
Jul 23, 2021
Downgrades: Neutral
Price Target: $230$30
Current: $4.23
Upside: +609.22%
RAPT Therapeutics
Jun 14, 2021
Maintains: Overweight
Price Target: $408$568
Current: $29.70
Upside: +1,812.46%
Maintains: Overweight
Price Target: $285$281
Current: $419.89
Upside: -33.08%
Initiates: Overweight
Price Target: $8
Current: $2.10
Upside: +280.95%
Maintains: Overweight
Price Target: $86$98
Current: $1.29
Upside: +7,496.90%
Maintains: Overweight
Price Target: $280$295
Current: $292.00
Upside: +1.03%
Reiterates: Overweight
Price Target: $84$86
Current: $118.44
Upside: -27.39%
Maintains: Overweight
Price Target: $30$48
Current: $34.02
Upside: +41.09%
Initiates: Overweight
Price Target: $30
Current: $8.76
Upside: +242.47%
Maintains: Overweight
Price Target: $70$72
Current: $43.18
Upside: +66.74%
Assumes: Overweight
Price Target: $5
Current: $1.94
Upside: +157.73%
Maintains: Neutral
Price Target: $83$100
Current: $92.59
Upside: +8.00%
Reiterates: Overweight
Price Target: $185$201
Current: $203.71
Upside: -1.33%
Reiterates: Overweight
Price Target: $86$85
Current: $68.11
Upside: +24.80%
Maintains: Overweight
Price Target: $30$32
Current: $12.12
Upside: +164.03%
Reiterates: Overweight
Price Target: $211$217
Current: $23.25
Upside: +833.33%
Maintains: Neutral
Price Target: $75$48
Current: $36.47
Upside: +31.62%
Downgrades: Underperform
Price Target: n/a
Current: $16.43
Upside: -
Maintains: Outperform
Price Target: $151$154
Current: $449.56
Upside: -65.74%
Maintains: Outperform
Price Target: $113$116
Current: $51.91
Upside: +123.46%
Maintains: Outperform
Price Target: $147$106
Current: $5.46
Upside: +1,841.39%
Maintains: Outperform
Price Target: $24$28
Current: $12.27
Upside: +128.29%
Maintains: Neutral
Price Target: $85$82
Current: $178.20
Upside: -53.98%
Initiates: Underperform
Price Target: n/a
Current: $453.53
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $3.38
Upside: -